1346600-54-1 (格列吡嗪杂质B,4-β-(6-Methylpyrazinyl-2-carboxamido)ethylbenzene Sulfonamide)

N-去(环己基氨基羰基)格列吡嗪;格列吡嗪EP杂质D;格列吡嗪杂质B;

N-Des(cyclohexylaminocarbonyl) Glipizide;4-[β-(6-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide;6-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide;6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide;Glipizide EP Impurity D;A899144;Q27264380;69SDY6K019;6-Methyl-N-(2-(4-sulfamoylphenyl)ethyl)pyrazine-2-carboxamide;2-PYRAZINECARBOXAMIDE, N-(2-(4-(AMINOSULFONYL)PHENYL)ETHYL)-6-METHYL-;6-Methyl-N-(4-sulfamoylphenethyl)pyrazine-2-carboxamide;DTXSID20158855;1346600-54-1;6-Methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide; Glipizide Imp. D (EP); Glipizide Related Compound B; Glipizide Impurity D;Glipizide impurity D;4-[beta-(6-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide;GLIPIZIDE IMPURITY D [EP IMPURITY];UNII-69SDY6K019;

ZBULFWLJSYSQEV-UHFFFAOYSA-N

1S/C14H16N4O3S/c1-10-8-16-9-13(18-10)14(19)17-7-6-11-2-4-12(5-3-11)22(15,20)21/h2-5,8-9H,6-7H2,1H3,(H,17,19)(H2,15,20,21)

S(C1C=CC(=CC=1)CCNC(C1C=NC=C(C)N=1)=O)(N)(=O)=O